(Q36614036)
Statements
1 reference
A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer (English)
1 reference
Y H Park
1 reference
B-S Kim
1 reference
B-Y Ryoo
1 reference
S H Yang
1 reference
1 April 2006
1 reference
1 reference
959-963
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference